Metropolitan Life Insurance Company (MetLife)’s CoreCard CCRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-399
Closed -$7.98K 2355
2023
Q3
$7.98K Hold
399
﹤0.01% 2314
2023
Q2
$10.1K Buy
+399
New +$10.3K ﹤0.01% 2292
2022
Q2
Sell
-488
Closed -$13.4K 2384
2022
Q1
$13.4K Sell
488
-1,492
-75% -$50.7K ﹤0.01% 2224
2021
Q4
$76.8K Hold
1,980
﹤0.01% 2605
2021
Q3
$80.4K Buy
+1,980
New +$70.5K ﹤0.01% 2638
2021
Q1
Sell
-2,274
Closed -$91.2K 2590
2020
Q4
$91.2K Hold
2,274
﹤0.01% 2397
2020
Q3
$88.6K Hold
2,274
﹤0.01% 2286
2020
Q2
$77.5K Hold
2,274
﹤0.01% 2396
2020
Q1
$77.3K Hold
2,274
﹤0.01% 2194
2019
Q4
$90.8K Hold
2,274
﹤0.01% 2384
2019
Q3
$94.5K Buy
+2,274
New +$102K ﹤0.01% 2333

Other funds holding CCRD

Metropolitan Life Insurance Company (MetLife)'s CCRD Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CoreCard (CCRD) in Q4 2023, closing a stake of 399 shares — an estimated $7.98K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CCRD in Q3 2019 and held it in 11 quarters. The position peaked at $94.5K in Q3 2019. 68 funds tracked by Wall St. Rank hold CCRD as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CoreCard position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 399 CoreCard shares in Q4 2023, an estimated $7.98K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CoreCard in Q3 2019 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CoreCard position peaked at $94.5K in Q3 2019.
  • 68 funds tracked by Wall St. Rank held CoreCard as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.